Drug Side Effects
Search
TUMEFACTIVE MULTIPLE SCLEROSIS
TUMEFACTIVE MULTIPLE SCLEROSIS
was reported 170 times
TUMEFACTIVE MULTIPLE SCLEROSIS is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Sphingosine 1-phosphate Receptor Modulator [EPC]
32
0.0023
1
CD52-directed Cytolytic Antibody [EPC]
5
0.0003
2
Interleukin-17A Antagonist [EPC]
9
0.0002
3
Integrin Receptor Antagonist [EPC]
21
0.0002
4
Pyrimidine Synthesis Inhibitor [EPC]
6
0.0001
5
Antirheumatic Agent [EPC]
10
0.0001
6
CD20-directed Cytolytic Antibody [EPC]
15
0.0000
7
Interferon beta [EPC]
8
0.0000
8
Provitamin D2 Compound [EPC]
1
0.0000
9
Sympathomimetic-like Agent [EPC]
1
0.0000
10
Calcineurin Inhibitor Immunosuppressant [EPC]
3
0.0000
11
Folate Analog Metabolic Inhibitor [EPC]
10
0.0000
12
Corticosteroid [EPC]
27
0.0000
13
Potassium Channel Blocker [EPC]
1
0.0000
14
HER2/neu Receptor Antagonist [EPC]
1
0.0000
15
Purine Antimetabolite [EPC]
1
0.0000
16
Thiazide Diuretic [EPC]
2
0.0000
17
Dihydropyridine Calcium Channel Blocker [EPC]
3
0.0000
18
Tumor Necrosis Factor Blocker [EPC]
9
0.0000
19
Estrogen [EPC]
1
0.0000
20
Proton Pump Inhibitor [EPC]
3
0.0000
21
Mood Stabilizer [EPC]
1
0.0000
22
Anti-epileptic Agent [EPC]
1
0.0000
23
Opioid Agonist [EPC]
1
0.0000
24
Progestin [EPC]
1
0.0000
25
Benzodiazepine [EPC]
2
0.0000
26
HMG-CoA Reductase Inhibitor [EPC]
1
0.0000
27
Atypical Antipsychotic [EPC]
1
0.0000
28
Nonsteroidal Anti-inflammatory Drug [EPC]
1
0.0000